SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Alcohol-Related Disorders D019973 3 associated lipids
Lead Poisoning D007855 4 associated lipids
Urinary Incontinence D014549 4 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Dyspepsia D004415 5 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Amnesia D000647 12 associated lipids
Glucose Intolerance D018149 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Brain Infarction D020520 17 associated lipids
Angina Pectoris D000787 27 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometriosis D004715 29 associated lipids
Stroke D020521 32 associated lipids
Memory Disorders D008569 33 associated lipids
Burns D002056 34 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Cataract D002386 34 associated lipids
Fever D005334 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Shao J et al. Spectroscopic and molecular docking studies of the in vitro interaction between puerarin and cytochrome P450. 2014 Molecules pmid:24743933
Liu Y et al. Amelioration of stroke-induced neurological deficiency by lyophilized powder of catapol and puerarin. 2014 Int. J. Biol. Sci. pmid:24719562
Ma JQ et al. Puerarin attenuates carbon tetrachloride-induced liver oxidative stress and hyperlipidaemia in mouse by JNK/c-Jun/CYP7A1 pathway. 2014 Basic Clin. Pharmacol. Toxicol. pmid:24698568
Chen G et al. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways. 2014 Acta Pharmacol. Sin. pmid:24608673
Jung HR et al. Simultaneous determination of puerarin and its active metabolite in human plasma by UPLC-MS/MS: application to a pharmacokinetic study. 2014 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:25264914
Zhang X et al. Puerarin protects dopaminergic neurons in Parkinson's disease models. 2014 Neuroscience pmid:25218963
Fu R et al. Digital gene expression analysis of the pathogenesis and therapeutic mechanisms of ligustrazine and puerarin in rat atherosclerosis. 2014 Gene pmid:25218235
Kim MH et al. Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease. 2014 Planta Med. pmid:25210998
Wang J et al. Synergistic effects of puerarin combined with 5-fluorouracil on esophageal cancer. 2014 Mol Med Rep pmid:25189132
Zhang WG et al. Puerarin inhibits growth and induces apoptosis in SMMC-7721 hepatocellular carcinoma cells. 2014 Mol Med Rep pmid:25175767
Wang C et al. Puerarin protects against β-amyloid-induced microglia apoptosis via a PI3K-dependent signaling pathway. 2014 Neurochem. Res. pmid:25173404
Xie N et al. Puerarin protects hippocampal neurons against cell death in pilocarpine-induced seizures through antioxidant and anti-apoptotic mechanisms. 2014 Cell. Mol. Neurobiol. pmid:25151533
Maji AK et al. Pueraria tuberosa: a review on its phytochemical and therapeutic potential. 2014 Nat. Prod. Res. pmid:24980468
Liu G et al. Puerarin protects against lead-induced cytotoxicity in cultured primary rat proximal tubular cells. 2014 Hum Exp Toxicol pmid:24505050
Tang L et al. The protective effects of puerarin in cardiomyocytes from anoxia/reoxygenation injury are mediated by PKCε. 2014 Cell Biochem. Funct. pmid:24496955
Tang F et al. Puerarin protects against Staphylococcus aureus-induced injury of human alveolar epithelial A549 cells via downregulating alpha-hemolysin secretion. 2014 Microb. Drug Resist. pmid:24372183
Zhou Y et al. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. 2014 Int. J. Neuropsychopharmacol. pmid:24345484
Wang N et al. Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. 2014 Neuropharmacology pmid:24333675
Liu Q et al. MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate. 2014 Pharm. Res. pmid:24242937
Liu Y et al. Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor κB pathways. 2014 Chin J Integr Med pmid:24122632
Chen YG et al. Metabolic differentiations of Pueraria lobata and Pueraria thomsonii using ¹H NMR spectroscopy and multivariate statistical analysis. 2014 J Pharm Biomed Anal pmid:23746990
Zhu G et al. Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice. 2014 Phytother Res pmid:23512787
Li Z et al. Puerarin protects pancreatic β-cell survival via PI3K/Akt signaling pathway. 2014 J. Mol. Endocrinol. pmid:24827001
Liu S et al. Puerarin blocks the signaling transmission mediated by P2X3 in SG and DRG to relieve myocardial ischemic damage. 2014 Brain Res. Bull. pmid:24447636
Xu J et al. A new flavonoid glycoside from the rhizomes and roots of Smilax scobinicaulis. 2014 Nat. Prod. Res. pmid:24483603
Mahdy HM et al. Puerarin ameliorates 3-nitropropionic acid-induced neurotoxicity in rats: possible neuromodulation and antioxidant mechanisms. 2014 Neurochem. Res. pmid:24346712
Zhou YX et al. Puerarin: a review of pharmacological effects. 2014 Phytother Res pmid:24339367
Zhong Y et al. Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. 2014 PLoS ONE pmid:24454919
Bao MH et al. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS. 2014 Can. J. Physiol. Pharmacol. pmid:24708212
Mahdy HM et al. The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats. 2014 Can. J. Physiol. Pharmacol. pmid:24593790
Wang XC et al. [Effect of chaperone-mediated autophagy in MPP(+) -induced SH-SY5Y cells and interventional effect of puerarin]. 2014 Zhongguo Zhong Yao Za Zhi pmid:24754178
Qu H et al. Development of an enzyme-linked immunosorbent assay based on anti-puerarin monoclonal antibody and its applications. 2014 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:24583873
Wu M et al. Effects of delayed puerarin treatment in long-term neurological outcomes of focal ischemic stroke in rats. 2014 Mar-Apr Indian J Pharmacol pmid:24741185
Gang C et al. Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways. 2015 J Pharm Pharm Sci pmid:26158288
Yu D et al. Puerarin attenuates glucocorticoid-induced apoptosis of hFOB1.19 cells through the JNK- and Akt-mediated mitochondrial apoptotic pathways. 2015 Int. J. Mol. Med. pmid:26101183
Cheng W et al. Puerarin improves cardiac function through regulation of energy metabolism in Streptozotocin-Nicotinamide induced diabetic mice after myocardial infarction. 2015 Biochem. Biophys. Res. Commun. pmid:26079885
Wenjun H et al. The Protective Effect of Puerarin on Myocardial Infarction Reperfusion Injury (MIRI): A Meta-Analysis of Randomized Studies in Rat Models. 2015 Med. Sci. Monit. pmid:26067875
Cui SQ et al. Puerarin protects against damage to spatial learning and memory ability in mice with chronic alcohol poisoning. 2015 Braz. J. Med. Biol. Res. pmid:25831201
Zheng G et al. Effects of puerarin on lipid accumulation and metabolism in high-fat diet-fed mice. 2015 PLoS ONE pmid:25822741
Guo XF et al. Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma. 2015 Mol Med Rep pmid:25434307
Liu AC et al. Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats. 2015 Chin J Nat Med pmid:25908622
Lv H et al. Puerarin enhances proliferation and osteoblastic differentiation of human bone marrow stromal cells via a nitric oxide/cyclic guanosine monophosphate signaling pathway. 2015 Mol Med Rep pmid:25892538
Zou ZJ et al. Intervention effects of puerarin on blood stasis in rats revealed by a (1)H NMR-based metabonomic approach. 2015 Phytomedicine pmid:25837270
Gray SL et al. Impact of kudzu and puerarin on sperm function. 2015 Reprod. Toxicol. pmid:25828059
Han P et al. Puerarin suppresses high glucose-induced MCP-1 expression via modulating histone methylation in cultured endothelial cells. 2015 Life Sci. pmid:25817234
Wang Z et al. Protective effects of edaravone combined puerarin on inhalation lung injury induced by black gunpowder smog. 2015 Int. Immunopharmacol. pmid:25754765
Zhang Y et al. The Puerarin improves renal function in STZ-induced diabetic rats by attenuating eNOS expression. 2015 Ren Fail pmid:25707518
Yang X et al. Puerarin decreases bone loss and collagen destruction in rats with ligature-induced periodontitis. 2015 J. Periodont. Res. pmid:25645818
Qu J et al. Puerarin alleviates noise-induced hearing loss via affecting PKCγ and GABAB receptor expression. 2015 J. Neurol. Sci. pmid:25592416
Kang OH et al. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. 2015 Int. J. Mol. Med. pmid:25605057